Quick Answer
OptimizeRx Corp reported Gross Profit of $73.60 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +23.9% in Gross Profit from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $652.6 thousand | Q3 2013: $843.9 thousand | Q1 2014: $728.0 thousand | Q2 2014: $696.7 thousand | Q3 2014: $861.1 thousand | Q1 2015: $731.1 thousand | Q2 2015: $823.1 thousand | Q3 2015: $963.0 thousand | Q1 2016: $866.7 thousand | Q2 2016: $990.5 thousand | Q3 2016: $1.06 million | Q1 2017: $770.3 thousand | Q2 2017: $1.26 million | Q3 2017: $1.40 million | Q1 2018: $2.10 million | Q2 2018: $2.86 million | Q3 2018: $3.15 million | Q1 2019: $3.63 million | Q2 2019: $4.32 million | Q3 2019: $3.02 million | Q1 2020: $4.34 million | Q2 2020: $5.14 million | Q3 2020: $6.01 million | Q1 2021: $6.12 million | Q2 2021: $8.04 million | Q3 2021: $9.08 million | Q1 2022: $8.10 million | Q2 2022: $8.99 million | Q3 2022: $9.42 million | Q1 2023: $7.43 million | Q2 2023: $7.83 million | Q3 2023: $9.80 million | Q1 2024: $12.20 million | Q2 2024: $11.70 million | Q3 2024: $13.45 million | Q1 2025: $13.34 million | Q2 2025: $18.64 million | Q3 2025: $17.52 million.
- Over the full 14 years of available data (2012 to 2025), OptimizeRx Corp's Gross Profit has grown by 3,827.7%.
- Historical annual values: Fiscal year 2025: $73.60 million | Fiscal year 2024: $59.38 million | Fiscal year 2023: $42.90 million | Fiscal year 2022: $38.97 million | Fiscal year 2021: $35.64 million | Fiscal year 2020: $24.11 million | Fiscal year 2019: $15.44 million | Fiscal year 2018: $12.21 million | Fiscal year 2017: $5.95 million | Fiscal year 2016: $4.34 million | Fiscal year 2015: $3.60 million | Fiscal year 2014: $3.28 million | Fiscal year 2013: $2.82 million | Fiscal year 2012: $1.87 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: